Drug Profile
Interferon alpha - Kancer
Alternative Names: Oral Interferon - KancerLatest Information Update: 12 Nov 2021
Price :
$50
*
At a glance
- Originator Kancer
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Interferon alpha stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Cancer in United Kingdom (PO)
- 06 Jul 2016 Early research in Cancer in United Kingdom (PO)